Repligen names Biogen exec to its board of directors

Repligen Corp., which recently sold off its internally-developed drug candidates in favor of selling products used in the manufacturing of biologic drugs, has nabbed an executive at Biogen Idec as the newest member of its board of directors...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.